DCF Advisers »

Miragen Therapeutics shares owned by DCF Advisers

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by DCF Advisers from 13F filings

Historical chart of DCF Advisers investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by DCF Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $254k 15k 17.51
2023-09-30 $207k 14k 15.34
2023-06-30 $452k 19k 23.79